Schedule 13D ownership disclosure
CHEMOMAB THERAPEUTICS LTD
Ordinary shares, no par value per share · CUSIP: 16385C203
Event date: 2026-11-03
- Filing-level shares
- 74,576,240.00
- Percent of class
- 10.4%
- Scipher Medicine CorpReported CIK 0001658821
Shares: 74,576,240.00 · Class: 10.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-051041
- Form type
- SCHEDULE 13D
- Filer
- Scipher Medicine Corp
- CIK
- CIK 1658821
- Filed
- Nov 10, 2026
- Reporting period
- Nov 03, 2026
- Description
- Schedule 13D beneficial ownership